Beta-carotene mediates its therapeutic effects on human neuroblastoma, including the inhibition of cancer stemness and metastasis, by suppressing the enzyme activity and expression of MMPs, as well as the expression of HIF-1α and its downstream targets [49]. This evidence concerns the gene HIF1A and neuroblastoma.